| Product Code: ETC7379765 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of respiratory virus vaccines to Grenada in 2024 were primarily sourced from Barbados, India, Panama, South Korea, and Belgium. The market experienced a shift from high concentration in 2023 to moderate concentration in 2024, indicating increased diversification of vaccine sources. With a notable compound annual growth rate (CAGR) of 24.01% from 2020 to 2024 and a significant growth rate of 67.54% from 2023 to 2024, the Grenada market for respiratory virus vaccines is showing strong momentum and potential for further expansion.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Respiratory Virus Vaccines Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Respiratory Virus Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Respiratory Virus Vaccines Market - Industry Life Cycle |
3.4 Grenada Respiratory Virus Vaccines Market - Porter's Five Forces |
3.5 Grenada Respiratory Virus Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Grenada Respiratory Virus Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 Grenada Respiratory Virus Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Grenada Respiratory Virus Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Grenada Respiratory Virus Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Respiratory Virus Vaccines Market Trends |
6 Grenada Respiratory Virus Vaccines Market, By Types |
6.1 Grenada Respiratory Virus Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Inactivated/Killed Vaccines, 2021- 2031F |
6.1.4 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Live-attenuated Vaccines, 2021- 2031F |
6.1.5 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Recombinant Vaccines, 2021- 2031F |
6.2 Grenada Respiratory Virus Vaccines Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.2.3 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Intranasal, 2021- 2031F |
6.2.4 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3 Grenada Respiratory Virus Vaccines Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3.3 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Adults, 2021- 2031F |
6.4 Grenada Respiratory Virus Vaccines Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Pharmacies/Stores, 2021- 2031F |
6.4.5 Grenada Respiratory Virus Vaccines Market Revenues & Volume, By Physician's Office, 2021- 2031F |
7 Grenada Respiratory Virus Vaccines Market Import-Export Trade Statistics |
7.1 Grenada Respiratory Virus Vaccines Market Export to Major Countries |
7.2 Grenada Respiratory Virus Vaccines Market Imports from Major Countries |
8 Grenada Respiratory Virus Vaccines Market Key Performance Indicators |
9 Grenada Respiratory Virus Vaccines Market - Opportunity Assessment |
9.1 Grenada Respiratory Virus Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Grenada Respiratory Virus Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 Grenada Respiratory Virus Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Grenada Respiratory Virus Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Grenada Respiratory Virus Vaccines Market - Competitive Landscape |
10.1 Grenada Respiratory Virus Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Grenada Respiratory Virus Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here